Your browser doesn't support javascript.
loading
Commercially Available Blocking Oligonucleotides Effectively Suppress Unwanted Hemolysis-Related miRNAs in a Large Whole-Blood RNA Cohort.
LaBelle, Jenna; Bowser, Mark; Brown, Alison; Farnam, Leanna; Kho, Alvin; Li, Jiang; McGeachie, Michael; Chase, Robert; Piehl, Shannon; Allen, Kevin; Hobbs, Brian D; Weiss, Scott T; Hersh, Craig; Tantisira, Kelan; Amr, Sami S.
Afiliación
  • LaBelle J; Mass General Brigham Personalized Medicine, Partners Healthcare, Cambridge, Massachusetts.
  • Bowser M; Mass General Brigham Personalized Medicine, Partners Healthcare, Cambridge, Massachusetts.
  • Brown A; Mass General Brigham Personalized Medicine, Partners Healthcare, Cambridge, Massachusetts.
  • Farnam L; School of Health Sciences, Lasell University, Auburndale, Massachusetts.
  • Kho A; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Li J; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • McGeachie M; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Chase R; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Piehl S; PerkinElmer Inc., Waltham, Massachusetts.
  • Allen K; PerkinElmer Inc., Waltham, Massachusetts.
  • Hobbs BD; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Weiss ST; Mass General Brigham Personalized Medicine, Partners Healthcare, Cambridge, Massachusetts; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Hersh C; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Tantisira K; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Amr SS; Mass General Brigham Personalized Medicine, Partners Healthcare, Cambridge, Massachusetts; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: samr@bwh.harvard.edu.
J Mol Diagn ; 23(6): 671-682, 2021 06.
Article en En | MEDLINE | ID: mdl-33872788
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligonucleótidos / ARN / MicroARNs / Hemólisis Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oligonucleótidos / ARN / MicroARNs / Hemólisis Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2021 Tipo del documento: Article